Diseases of the breast by Vaidya, J S et al.
Searching National Library of Medicine’s PubMed for the
keyword ‘breast’ yields 31 988 new articles between 1996 and
1999. The editors of Diseases of the Breast have taken up the
challenge of incorporating the most important and relevant bits of
this new knowledge into their second edition; and they have done
well. 
Starting with the excellent chapters on anatomy and development
– including its biochemical control – this clinician-oriented book
goes straight onto management of disease. The importance of
management of benign breast disease cannot be overemphasized.
It affects the younger woman and the most important task of the
clinician is to reassure the worried young woman without missing
the rare sinister pathology. It is well worth noting that although a
minority of this group has a cancer, missing it contributes to most
lawsuits in the field. Being under the media microscope, it takes
courage to reassure these women without practising too much
defensive medicine. The algorithms in this chapter are useful, 
but must be read along with the text, which elaborates on the
complexity of the management decisions that cannot be laid down
in a simple algorithm. Toe amputation always cures an ingrowing
toenail but this is usually not considered the best option. The 
false-negative rate of a properly conducted triple assessment can
be less than 1% and this can save many a women an unnecessary
biopsy. 
We have known the two breast cancer genes BRCA-1 and
BRCA-2 for some years, and recent findings indicate that there
probably are many more less penetrant genes that are yet to be
identified. Public knowledge of these genes has forced the profes-
sion to devise ways to tackle the difficult and delicate issue of
managing the worried well. Experts in the field have shared their
wisdom at great length, covering these new areas in detail. There
are separate and well written chapters on chemoprevention and
prophylactic mastectomy. In addition, the non-genetic risks of
breast cancer – which are probably modifiable – are discussed.
The complex discussion on balancing the risks and benefits of
mutilating interventions in high-risk individuals is well presented. 
The section on natural history of breast cancer has explored the
radical conceptual changes in the last century, including the
Halstedian concept of orderly spread of breast cancer, Fisher’s
view of pre-clinical systemic spread, and the combination/spec-
trum of these two concepts. The recent publication of the Danish
radiotherapy trials, which suggested that in certain groups of
women post-mastectomy radiotherapy may actually improve
survival in patients receiving chemotherapy, contradicts the cumu-
lated evidence from randomized trials, that has been presented in
the Oxford overview several times, that nuances of local treatment
do not have a great impact on survival. We were hoping that there
would be some enlightening discussion on this paradox – but
perhaps this is not a place for novel ideas. 
The pathogenesis – genetic and endocrine – of breast cancer,
and the various types of pathology, are very well covered in
separate chapters. The local treatment options of in situ and
invasive breast cancer are described very well and so also are
special situations like locally advanced breast cancer, pregnancy
and cancer, male breast cancer, lymphoedema and occult primary
with axillary metastasis. The sensitive topics like treatment 
of in situ cancer, evaluation of patients after primary therapy,
breast reconstruction and psychosocial aspects are discussed in
detail. 
In this book, metastatic disease is presented in great detail 
and takes up nearly a third of the book. There is a full discussion
about the pros and cons of follow-up after active treatment is
completed and several clinical, economic and psychological 
issues are well addressed. The standard treatments as well as
newer methods of treatment of metastasis have been dealt 
with extensively. The clinical appearance of distant metastasis
many years after treatment of primary tumour has remained a
mystery despite all advances in the molecular and clinical
research. Intense research about growth factors, angiogenesis,
apoptosis and the host–metastasis equilibrium is now reaching the
bedside. These newer and complex developments are covered in a
lucid manner in the book. Detailed overviews of novel treatment
modalities using angiogenesis as a therapeutic target, immuno-
therapy and biologic as are presented in individual chapters. 
The section on breast imaging covers the latest advances in
image-guided biopsy techniques. These techniques, especially the
vacuum-assisted core biopsy (Mammotome) have brought great
change in diagnostic work-up of patients with non-palpable breast
lesions, avoiding a surgical biopsy in most cases. The excellent
chapter on screening includes a section on ‘risk-based’ screening
guidelines, which unfortunately usually have to be based on expert
opinion only. A discussion on the risks of screening and therefore
what an informed consent for screening should include is sadly
lacking. This is particularly relevant today, with very sensitive
imaging technology that has started uncovering more and more
‘pseudodisease’ that may never have manifested in the woman’s
lifetime. Physical breast examination should have received more
coverage, since this may be the only feasible intervention in de-
veloping countries and may have the advantage of being able to
identify only the potentially fatal cancers. 
There are four useful chapters on research methods, techniques
of molecular biology and of conducting clinical trials, and assess-
ment of quality of life and cost-effectiveness. In addition, medico-
legal issues have a chapter devoted to them.
Diseases of the Breast provides extensive coverage of the whole
spectrum of issues in breast cancer, with special emphasis on
management, while not losing sight of the basic science and
patient-related factors. The extensive referencing of every chapter
appears to be editorial policy and many of the classic studies
should be very useful, as should be the management summaries at
the end of relevant chapters. Colour illustrations, especially for
some inflammatory conditions, reconstructive procedures and
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– perhaps in the next edition. 
One of us had reviewed the first edition of Diseases of the
Breast in 1996 and was very impressed – the second edition is as
impressive and the content is thoroughly updated. It can therefore
be repeated that ‘this book deserves a place on the desk of anyone
interested in the subject’. 
Jayant S Vaidya, Mohammed Keshtgar and Michael Baum 
Department of Surgery, University College London, 
67–73 Riding House Street, London W1P 7LD, UK
Clinical Oncology, 2nd edn 
MD Abeloff, JO Armitage, AS Lichtes and JE Niederhuber 
Churchill Livingstone: Philadelphia
This is the second edition of this large textbook, which first
appeared in 1995. It is one of several books that aim to give a
comprehensive account of the science, clinical features and
management of cancer. 
The growth of electronic libraries and reference systems in the
1990s worried medical publishers, particularly with respect to books
like this. Would clinicians continue to use them? It turns out that
they do. The reasons are obvious. It’s much easier to look something
up quickly in a book than to turn on your computer and struggle
through complex sorting procedures to find information that you
then have to read on a screen. Books are easy to browse, to dip into,
to find something quickly, to read on a train (although at 4.5 kg you
wouldn’t want this one to fall out of an overhead luggage rack). A
good book, writen to educate rather than to review current knowl-
edge, has a different purpose from a collection of reviews. This 
one is aimed at trainee and practising oncologists, as well as non-
specialists. It is a work of instruction and reference with a wide
audience. For the editors and publishers this means achieving
consistency of style and content. They have succeeded admirably. 
To start with the basics. It is 3000 pages long has 223 contribu-
tors, nearly all of whom are from North America. It is nicely
printed on paper with little see-through and with figures, tables
and colour prints that are, in the main, well thought out and with a
certain consistency and logic from chapter to chapter. The general
layout is conventional. It starts with the scientific underpinnings of
cancer medicine, moves on to the general principles of manage-
ment. It correctly places supportive care early in the book rather
than after the sections on specific cancers that follow. 
I always find the science parts of these books less useful than
the clinical. They are usually mini-reviews and often do not deal
conceptually with the subject at a level which will really engage
the reader. The authors, basic scientists of high repute, often show
little understanding of what the reader will wish to know, or where
he or she might have difficulty in understanding. If the function of
these sections is to teach and to explain, the text must concern
itself with the clear exposition of principles. In this book many of
the contributions are first-rate from this point of view. These chap-
ters have good diagrams to explain difficult ideas. It’s curious,
though, that there is cumulatively much more space devoted to the
science of potential biological treatments – most of which are of
uncertain value – than there is to the scientific basis of drug treat-
ment – which often works. As usual there are hundreds of refer-
ences in these and the other chapters. These have become an
obsession in medical writing. It seems that you can’t write that
patients are anxious about the diagnosis of cancer without giving
three references. Who uses these lists? Why don’t we limit
ourselves, in textbooks of medical education and practice, to refer-
ences to really good reviews or essential original articles? 
The sections on the general aspects of cancer management –
metastases, effusions, cord compression, paraneoplastic syn-
dromes, nausea, cachexia, fever – are excellent. Here, as elsewhere
in the book, there are summary boxes and algorithms which will
help the physician, especially the trainee. The advice on diagnosis
and management is clear and written concisely. I found myself
occasionally at odds with some of the recommendations. Mostly
this was when advice was being given about treatment, in situa-
tions where there is no chance of cure, without the option of not
treating being considered. This remark will doubtless be seen as a
typical example of UK nihilism and attributed to our health care
system. It isn’t. It’s good practice not to give active treatment
sometimes. 
How does a reviewer give a fair account of the remaining 2000
pages of the specific tumours? I had this book for 6 months before
writing this review – to the immense frustration of the Editor of the
Journal. The reason was that I used it to look things up when I
wasn’t sure of my facts. It’s a good test of whether a book actually
works I think. It seldom let me down. I found it easy to find my way
around. I read the sections on lung cancer, lymphoma, bone and
soft-tissue sarcoma and childhood cancer thoroughly, and indi-
vidual problems in many of the other sections. I found the descrip-
tion of the clinical features to be very good, the advice about
diagnosis and staging to be sensible and straightforward, and the
approach to management to be up-to-date and clear. There is a
tendency for chemotherapy to be given a greater weight in some
cancers than the results actually justify, but this probably reflects a
feature of North American practice. There was one area of real
confusion and that is in the discussion of round cell sarcomas of
bone. This has found its way into two chapters, neither of which
deals with the management well. 
The graphic illustration is clear, the clinical algorithms are
useful. The tables of chemotherapy regimens are highly selected
(they always are) and reflect the authors’ own preoccupations, but
those that I looked at in detail seemed to me to be a fair summary
of the most useful modern regimens. 
In summary, this is a first-rate book. I congratulate the Editors. I
know what a task it must have been to ensure consistency of style
and content and to achieve a balance between the chapters. It will
be in every oncologist’s library. In my view it is one of the best big
books on cancer. 
Robert Souhami 
Royal Free and University College Medical School, 
University College London, 
Gower Street, 
London WCIE 6BT, UK  
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